Specific inhibition of nitric oxide synthases at different time points in a murine model of pulmonary sepsis

Biochemical and Biophysical Research Communications

Volumn 404, Issue 3, 2011, Pages 877-881

  Lange, Matthias ^a,b   Hamahata, Atsumori ^a   Traber, Daniel L ^a   Nakano, Yoshimitsu ^a   Traber, Lillian D ^a   Enkhbaatar, Perenlei ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Malondialdehyde; Mice; Neuronal nitric oxide synthase; Oxidative stress; Survival

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MALONALDEHYDE; NEURONAL NITRIC OXIDE SYNTHASE; NITRATE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME INHIBITION; FEMALE; LIPID PEROXIDATION; LIVER HOMOGENATE; LUNG INFECTION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SEPSIS; SHAM PROCEDURE; SURVIVAL; SURVIVAL RATE; WILD TYPE;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; LIVER; LUNG DISEASES; MALONDIALDEHYDE; MICE; MICE, INBRED C57BL; NITRIC ACID; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; PSEUDOMONAS AERUGINOSA; SEPSIS;

ANIMALIA; MURINAE; MUS; PSEUDOMONAS AERUGINOSA;

EID: 78751629842     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.12.078     Document Type: Article

References (19)

1. Annane D., Aegerter P., Jars-Guincestre M.C., Guidet B. Current epidemiology of septic shock: the CUB-Rea network. Am. J. Respir. Crit. Care Med. 2003, 168:165-172.
2. Landry D.W., Oliver J.A. The pathogenesis of vasodilatory shock. N. Engl. J. Med. 2001, 345:588-595.
3. Szabo C. The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock 1996, 6:79-88.
4. Szabo C., Ischiropoulos H., Radi R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat. Rev. Drug Discov. 2007, 6:662-680.
5. Jagtap P., Szabo C. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat. Rev. Drug Discov. 2005, 4:421-440.
6. Virag L., Szabo C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol. Rev. 2002, 54:375-429.
7. Lange M., Nakano Y., Traber D.L., Hamahata A., Esechie A., Jonkam C., Bansal K., Traber L.D., Enkhbaatar P. Role of different nitric oxide synthase isoforms in a murine model of acute lung injury and sepsis. Biochem. Biophys. Res. Commun. 2010, 399:286-291.
8. Enkhbaatar P., Murakami K., Shimoda K., Mizutani A., McGuire R., Schmalstieg F., Cox R., Hawkins H., Jodoin J., Lee S., Traber L., Herndon D., Traber D. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole attenuates acute lung injury in an ovine model. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 285:R366-372.
9. Enkhbaatar P., Murakami K., Traber L.D., Cox R., Parkinson J.F., Westphal M., Esechie A., Morita N., Maybauer M.O., Maybauer D.M., Burke A.S., Schmalstieg F.C., Hawkins H.K., Herndon D.N., Traber D.L. The inhibition of inducible nitric oxide synthase in ovine sepsis model. Shock 2006, 25:522-527.
10. Lange M., Connelly R., Traber D.L., Hamahata A., Cox R.A., Nakano Y., Bansal K., Esechie A., von Borzyskowski S., Jonkam C., Traber L.D., Hawkins H.K., Herndon D.N., Enkhbaatar P. Combined neuronal and inducible nitric oxide synthase inhibition in ovine acute lung injury. Crit. Care Med. 2009, 37:223-229.
11. Okamoto I., Abe M., Shibata K., Shimizu N., Sakata N., Katsuragi T., Tanaka K. Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture. Am. J. Respir. Crit. Care Med. 2000, 162:716-722.
12. Lange M., Hamahata A., Traber D.L., Esechie A., Jonkam C., Bansal K., Nakano Y., Traber L.D., Enkhbaatar P. A murine model of sepsis following smoke inhalation injury. Biochem. Biophys. Res. Commun. 2010, 391:1555-1560.
13. Lange M., Nakano Y., Traber D.L., Hamahata A., Esechie A., Jonkam C., Bansal K., Traber L.D., Enkhbaatar P. Role of different nitric oxide synthase isoforms in a murine model of acute lung injury and sepsis. Biochem. Biophys. Res. Commun. 2010, 399:286-291.
14. Tao W., Deyo D.J., Traber D.L., Johnston W.E., Sherwood E.R. Hemodynamic and cardiac contractile function during sepsis caused by cecal ligation and puncture in mice. Shock 2004, 21:31-37.
15. Fagon J.Y., Chastre J., Hance A.J., Montravers P., Novara A., Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am. J. Med. 1993, 94:281-288.
16. Leu H.S., Kaiser D.L., Mori M., Woolson R.F., Wenzel R.P. Hospital-acquired pneumonia. Attributable mortality and morbidity. Am. J. Epidemiol. 1989, 129:1258-1267.
17. Vincent J.L., Sakr Y., Sprung C.L., Ranieri V.M., Reinhart K., Gerlach H., Moreno R., Carlet J., Le Gall J.R., Payen D. Sepsis in European intensive care units: results of the SOAP study. Crit. Care Med. 2006, 34:344-353.
18. M. Lange, A. Hamahata, D.L. Traber, Y. Nakano, A. Esechie, C. Jonkam, E.B. Whorton, S. von Borzyskowski, L.D. Traber, P. Enkhbaatar, Effects of early neuronal and delayed inducible nitric oxide synthase blockade on cardiovascular, renal, and hepatic function in ovine sepsis, Anesthesiology, Epub ahead of print.
19. Lopez A., Lorente J.A., Steingrub J., Bakker J., McLuckie A., Willatts S., Brockway M., Anzueto A., Holzapfel L., Breen D., Silverman M.S., Takala J., Donaldson J., Arneson C., Grove G., Grossman S., Grover R. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit. Care Med. 2004, 32:21-30.